Literature DB >> 15458591

Operative findings and outcomes of microvascular decompression for trigeminal neuralgia in 35 patients affected by multiple sclerosis.

Giovanni Broggi1, Paolo Ferroli, Angelo Franzini, Vittoria Nazzi, Laura Farina, Loredana La Mantia, Clara Milanese.   

Abstract

OBJECTIVE: The concept of vascular compression of the trigeminal root as the main etiological factor in idiopathic trigeminal neuralgia has achieved widespread acceptance, and microvascular decompression (MVD) is a well-established surgical procedure for its treatment. Multiple sclerosis (MS) has long been considered to be an absolute contraindication to MVD because of the supposed exclusive causative role of a demyelinating lesion affecting the trigeminal root entry zone. Magnetic resonance imaging preoperative identification of suspicious vessels along the cisternal course of the trigeminal nerve in MS patients raises the question of a possible causative role of vascular compression in MS patients.
METHODS: We describe magnetic resonance imaging findings, surgical findings, and outcomes in 35 MS patients who underwent MVD for medically intractable trigeminal neuralgia. Results were assessed by clinical follow-up and periodic phone surveys. The mean follow-up was 44 months (range, 6-108 mo).
RESULTS: Magnetic resonance imaging revealed the presence of demyelinating lesions affecting the brainstem trigeminal pathways of the painful side in 26 (74%) of 35 patients. During surgery, severe neurovascular compression at the trigeminal root entry zone was found in 16 (46%) of 35 patients. The long-term outcome was excellent in 39%, good in 14%, fair in 8%, and poor in 39% of patients. No statistically significant prognostic factor predicting good outcome could be found. There was no mortality, with a 2.5% long-term morbidity rate (facial nerve palsy in one patient).
CONCLUSION: Results of MVD in trigeminal neuralgia MS patients are much less satisfactory than in the idiopathic group, indicating that central mechanisms play a major role in pain genesis.

Entities:  

Mesh:

Year:  2004        PMID: 15458591

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  16 in total

1.  Microvascular Decompression for Trigeminal Neuralgia in Patients with Multiple Sclerosis: Predictors of Treatment Success.

Authors:  Danika L Paulo; Alexander M Lopez; Walter J Jermakowicz; Hong Yu; Hamid Shah; Peter E Konrad; Dario J Englot
Journal:  World Neurosurg       Date:  2019-12-23       Impact factor: 2.104

2.  Pain Outcomes Following Microvascular Decompression for Drug-Resistant Trigeminal Neuralgia: A Systematic Review and Meta-Analysis.

Authors:  Katherine Holste; Alvin Y Chan; John D Rolston; Dario J Englot
Journal:  Neurosurgery       Date:  2020-02-01       Impact factor: 4.654

Review 3.  Multiple sclerosis-related central pain disorders.

Authors:  Turo J Nurmikko; Sameer Gupta; Kate Maclver
Journal:  Curr Pain Headache Rep       Date:  2010-06

Review 4.  Botulinum Toxin Treatment in Multiple Sclerosis-a Review.

Authors:  Yasaman Safarpour; Tahereh Mousavi; Bahman Jabbari
Journal:  Curr Treat Options Neurol       Date:  2017-08-17       Impact factor: 3.598

5.  Treatment options in trigeminal neuralgia.

Authors:  Mark Obermann
Journal:  Ther Adv Neurol Disord       Date:  2010-03       Impact factor: 6.570

Review 6.  Surgical treatment of pediatric trigeminal neuralgia: case series and review of the literature.

Authors:  Matthew T Bender; Gustavo Pradilla; Carol James; Shaan Raza; Michael Lim; Benjamin S Carson
Journal:  Childs Nerv Syst       Date:  2011-10-01       Impact factor: 1.475

Review 7.  Trigeminal neuralgia.

Authors:  Joanna M Zakrzewska; Mark E Linskey
Journal:  BMJ Clin Evid       Date:  2014-10-06

Review 8.  Trigeminal neuralgia: diagnosis and treatment.

Authors:  William P Cheshire
Journal:  Curr Neurol Neurosci Rep       Date:  2005-03       Impact factor: 5.081

Review 9.  Pain and multiple sclerosis: pathophysiology and treatment.

Authors:  Claudio Solaro; Erika Trabucco; Michele Messmer Uccelli
Journal:  Curr Neurol Neurosci Rep       Date:  2013-01       Impact factor: 5.081

Review 10.  Current management of pain associated with multiple sclerosis.

Authors:  Walter Pöllmann; Wolfgang Feneberg
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.